Issues that may arise in primary care around Direct to Consumer genomic tests.
For the first part of this week, we are going to focus on direct-to-consumer (DTC) genetic testing. We will cover what is provided, pros and cons and how we can manage results that are brought to us in primary care.
In order to do this, we are going to try to help you understand the following issues as this will help you to explain the clinical relevance of a DTC result to your patients:
How NGS or next generation sequencing has changed genetic testing capability
How variants from the reference genome can be classed as significant, benign or unknown
What general testing strategies are offered to consumers
The interaction between genetics and environment influencing the phenotype displayed
How this knowledge helps us manage a patient presenting with a DTC report
In the second part of the week, we will look for interest into the application of genetic technologies in infectious disease